Encompass Health Corporation header image

Encompass Health Corporation

EHC

Equity

ISIN null / Valor 39085960

New York Stock Exchange, Inc (2025-11-19)
USD 111.92-0.67%

Encompass Health Corporation
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Encompass Health Corporation is a healthcare services company that provides post-acute care and rehabilitation services.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.11.2025):

Encompass Health Corporation's financial report for Q3 2025 shows robust performance with notable improvements over Q3 2024. The company delivered higher net operating revenue, earnings per share, and adjusted EBITDA, complemented by strategic operational expansions such as new hospital openings that strengthen its leadership in inpatient rehabilitation.

Revenue Growth

Net operating revenue climbed to $1,477.5 million in Q3 2025, up $126.5 million (9.4%) from Q3 2024, reflecting solid demand and operational scalability.

Earnings Improvement

Earnings per share from continuing operations increased from $1.07 in Q3 2024 to $1.24 in Q3 2025, representing a 15.9% rise. Adjusted EPS also advanced by 19.4%, underlining enhanced profitability.

Adjusted EBITDA Performance

Adjusted EBITDA rose by 11.4%, from $269.3 million in Q3 2024 to $300.1 million in Q3 2025, showcasing improved operating efficiency.

Operational Expansion

The quarter saw the opening of three new hospitals—including the first in Connecticut—along with the addition of 39 beds to existing facilities, which increases the company’s capacity to serve patients in need of inpatient rehabilitation care.

Guidance Upgrade

The company also raised its full-year 2025 guidance for net operating revenue, adjusted EBITDA, and EPS, signaling strong confidence in its long-term operational outlook and market position.

Summarized from source with an LLMView Source

Key figures

12.9%1Y
99.9%3Y
42.0%5Y

Performance

26.6%1Y
23.5%3Y
27.0%5Y

Volatility

Market cap

11261 M

Market cap (USD)

Daily traded volume (Shares)

614,616

Daily traded volume (Shares)

1 day high/low

93.4 / 92.15

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.22%EUR 26.48
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.22%EUR 9.03
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%EUR 26.45
Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.90%EUR 110.65
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.79%EUR 46.69
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 520878
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%EUR 39.52
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.86%EUR 35.30
AbbVie Inc
AbbVie Inc AbbVie Inc Valor: 20145667
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.41%USD 232.91
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 24.88
Revolution Medicines Inc
Revolution Medicines Inc Revolution Medicines Inc Valor: 52143299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.07%USD 70.53